In the first survey we were able to collect valuable information on the shortcomings of healthcare and identify the main problems patients faced due to the COVID-19 pandemic.
To find out whether these problems persist or have been solved, we need to know your experience.
Your participation is important to understand the impact of the pandemic on patients with rheumatic diseases and, in this way, to establish measures to reduce the impact and improve the care and quality of life of this group.
Results from the REUMAVID project are generating wide interest as all five abstracts presented by the REUMAVID working group have
he main manuscript of the REUMAVID project, “Assessment of the Impact of the COVID-19 from the Perspective of Patients with
The results of the first phase of the REUMAVID study will be presented next Monday April the 14th 2021 at the
Results from the REUMAVID project are generating wide interest as all five abstracts presented by the REUMAVID working group have
he main manuscript of the REUMAVID project, “Assessment of the Impact of the COVID-19 from the Perspective of Patients with
The results of the first phase of the REUMAVID study will be presented next Monday April the 14th 2021 at the
REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)
